Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5526
Morningstar
MORN
$7.73B
| $1.92M | ﹤0.01% |
7,945
+5,653
| +247% | +$1.42M |
|
5527
CALL
ZTO Express
ZTO
$17.4B
| $1.92M | ﹤0.01% |
69,900
-52,600
| -43% | -$1.35M |
|
5528
PUT
Rapid7
RPD
$828M
| $1.92M | ﹤0.01% |
28,700
-43,100
| -60% | -$3.56M |
|
5529
PUT
A.O. Smith
AOS
$8.38B
| $1.91M | ﹤0.01% |
35,000
+14,000
| +67% | +$840K |
|
5530
Globalstar
GSAT
$10.7B
| $1.91M | ﹤0.01% |
103,752
+101,965
| +5,706% | +$1.89M |
|
|
CIVI
5531
DELISTED
Civitas Resources
CIVI
| $1.91M | ﹤0.01% |
36,550
+31,227
| +587% | +$2.04M |
|
|
ALTR
5532
CALL
DELISTED
Altair Engineering Inc
ALTR
| $1.91M | ﹤0.01% |
+36,400
| New | +$1.99M |
|
5533
PUT
Commercial Metals
CMC
$8B
| $1.91M | ﹤0.01% |
57,700
-48,000
| -45% | -$1.89M |
|
5534
Principal Exchange-Traded Funds Principal Quality ETF
PSET
$29.1M
| $1.91M | ﹤0.01% |
+39,918
| New | +$2.04M |
|
|
HT
5535
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $1.91M | ﹤0.01% |
194,269
-25,058
| -11% | -$251K |
|
5536
CALL
Vicor
VICR
$11.6B
| $1.91M | ﹤0.01% |
34,800
-28,400
| -45% | -$1.76M |
|
5537
CALL
Ionis Pharmaceuticals
IONS
$9.67B
| $1.9M | ﹤0.01% |
51,400
+13,700
| +36% | +$517K |
|
5538
AllianceBernstein
AB
$3.38B
| $1.9M | ﹤0.01% |
45,749
-131,273
| -74% | -$5.51M |
|
5539
Principal Spectrum Preferred Securities Active ETF
PREF
$1.79B
| $1.9M | ﹤0.01% |
110,136
-380,133
| -78% | -$6.85M |
|
|
HEP
5540
DELISTED
Holly Energy Partners, L.P.
HEP
| $1.9M | ﹤0.01% |
118,581
+80,373
| +210% | +$1.44M |
|
|
GBT
5541
CALL
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $1.9M | ﹤0.01% |
59,500
-15,400
| -21% | -$451K |
|
5542
PUT
Jackson Financial
JXN
$9.09B
| $1.9M | ﹤0.01% |
71,000
+14,460
| +26% | +$527K |
|
|
NTST
5543
NETSTREIT Corp
NTST
$2.07B
| $1.9M | ﹤0.01% |
100,553
+1,263
| +1% | +$26.6K |
|
5544
PUT
ProShares UltraPro Short Dow 30
SDOW
$176M
| $1.89M | ﹤0.01% |
12,800
+1,925
| +18% | +$252K |
|
5545
DNOW Inc
DNOW
$2.94B
| $1.89M | ﹤0.01% |
193,551
-40,978
| -17% | -$436K |
|
5546
PUT
First Trust Cloud Computing ETF
SKYY
$3.31B
| $1.89M | ﹤0.01% |
28,700
-4,700
| -14% | -$346K |
|
|
OHPA
5547
DELISTED
Orion Acquisition Corp. Class A common stock
OHPA
| $1.89M | ﹤0.01% |
193,032
+130
| +0.1% | +$1.27K |
|
5548
CALL
Vanguard Morningstar Mega Cap Growth ETF
MGK
$33.7B
| $1.89M | ﹤0.01% |
52,000
-32,000
| -38% | -$1.29M |
|
|
ABCM
5549
DELISTED
Abcam PLC
ABCM
| $1.89M | ﹤0.01% |
130,697
+22,182
| +20% | +$343K |
|
5550
iShares MSCI South Korea ETF
EWY
$29.3B
| $1.89M | ﹤0.01% |
32,455
-363,206
| -92% | -$23.8M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.